BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12407770)

  • 1. Use of antisense oligonucleotides for therapy. Manipulation of apoptosis inhibitors for destruction of lung cancer cells.
    Leech SH; Olie RA; Zangemeister-Wittke U
    Methods Mol Med; 2003; 75():655-70. PubMed ID: 12407770
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.
    Xia C; Xu Z; Yuan X; Uematsu K; You L; Li K; Li L; McCormick F; Jablons DM
    Mol Cancer Ther; 2002 Jul; 1(9):687-94. PubMed ID: 12479365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.
    Hopkins-Donaldson S; Cathomas R; Simões-Wüst AP; Kurtz S; Belyanskaya L; Stahel RA; Zangemeister-Wittke U
    Int J Cancer; 2003 Aug; 106(2):160-6. PubMed ID: 12800189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells.
    Dai DJ; Lu CD; Lai RY; Guo JM; Meng H; Chen WS; Gu J
    World J Gastroenterol; 2005 Jan; 11(2):193-9. PubMed ID: 15633214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of programmed cell death with an antisense Bcl-2 oligonucleotide.
    Koty PP; Lei W; Levitt ML
    Methods Mol Med; 2003; 75():671-84. PubMed ID: 12407771
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U; Leech SH; Olie RA; Simões-Wüst AP; Gautschi O; Luedke GH; Natt F; Häner R; Martin P; Hall J; Nalin CM; Stahel RA
    Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of drug-resistant human ovarian carcinoma cell line COC1/DDP induced by survivin antisense oligonucleotides.
    Zheng F; Ruan F; Xie XK; Liu SY
    Chin Med J (Engl); 2006 Sep; 119(18):1572-5. PubMed ID: 16996013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of survivin targeting on cell proliferation and apoptosis in pancreatic cancer cells].
    Dai DJ; Lu CD; Lai RY; Guo JM; Meng H
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1894-8. PubMed ID: 15631802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin inhibits apoptosis in cytotrophoblasts.
    Shiozaki A; Kataoka K; Fujimura M; Yuki H; Sakai M; Saito S
    Placenta; 2003 Jan; 24(1):65-76. PubMed ID: 12495661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
    Gunawardena K; Campbell LD; Meikle AW
    Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Up-expression of IL-6 and down-expression of TNFalpha may be involved in the regulation of apoptosis induced by antisense bcl-2 oligodeoxynucleotides].
    Chen X; Hu J; Chen Z; Lu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Dec; 19(6):495-8. PubMed ID: 12476423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model.
    Leung S; Miyake H; Zellweger T; Tolcher A; Gleave ME
    Int J Cancer; 2001 Mar; 91(6):846-50. PubMed ID: 11275990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ponicidin, an ent-kaurane diterpenoid derived from a constituent of the herbal supplement PC-SPES, Rabdosia rubescens, induces apoptosis by activation of caspase-3 and mitochondrial events in lung cancer cells in vitro.
    Liu JJ; Huang RW; Lin DJ; Peng J; Zhang M; Pan X; Hou M; Wu XY; Lin Q; Chen F
    Cancer Invest; 2006 Mar; 24(2):136-48. PubMed ID: 16537182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of antisense oligodeoxynucleotide targeting survivin gene for cisplatin resistant human lung adeno-carcinoma xenograft in nude mice].
    Zhang MC; Hu CP; Chen Q; Xia Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):717-22. PubMed ID: 17062938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.
    Rückert F; Samm N; Lehner AK; Saeger HD; Grützmann R; Pilarsky C
    BMC Cancer; 2010 Jul; 10():379. PubMed ID: 20646298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.